RNASEL, an enzyme central to interferon-related antiviral and apoptotic responses, has been linked to increased risk for CESC, head and neck squamous cell carcinomas, and breast cancer through single nucleotide polymorphisms such as rs3738579 [37]. Here, RNASEL is linked to breast carcinoma.